{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T08:26:26Z","timestamp":1776673586347,"version":"3.51.2"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007162","name":"Guangdong Provincial Department of Science and Technology","doi-asserted-by":"crossref","award":["2024A0505040020"],"award-info":[{"award-number":["2024A0505040020"]}],"id":[{"id":"10.13039\/501100007162","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15839-0","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T01:36:28Z","timestamp":1773106588000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of a SHAP-explainable preoperative predictive model for microvascular invasion in hepatocellular carcinoma"],"prefix":"10.1186","volume":"26","author":[{"given":"Jianxi","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honggui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yucong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sina","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"15839_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17\u201348. https:\/\/doi.org\/10.3322\/caac.21763.","journal-title":"CA Cancer J Clin"},{"key":"15839_CR2","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","volume":"82","author":"European Association for the Study of the Liver","year":"2025","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines on the management of hepatocellular carcinoma. J Hepatol. 2025;82:315\u201374. https:\/\/doi.org\/10.1016\/j.jhep.2024.08.028.","journal-title":"J Hepatol"},{"key":"15839_CR3","first-page":"407","volume":"13","author":"Department of Medical. Administration, National Health Commission of the People\u2019s Republic of China","year":"2024","unstructured":"Department of Medical. Administration, National Health Commission of the People\u2019s Republic of China. Guidelines for diagnosis and treatment of primary liver cancer. Chin J Hepat Surg (Electronic Edition). 2024;13:407\u201349.","journal-title":"Chin J Hepat Surg (Electronic Edition)"},{"key":"15839_CR4","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1097\/SLA.0000000000000710","volume":"261","author":"P Tabrizian","year":"2015","unstructured":"Tabrizian P, Jibara G, Shrager B, Schwartz M, Roayaie S. Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. Ann Surg. 2015;261:947\u201355. https:\/\/doi.org\/10.1097\/SLA.0000000000000710.","journal-title":"Ann Surg"},{"key":"15839_CR5","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.jhep.2017.09.016","volume":"68","author":"N Fujiwara","year":"2018","unstructured":"Fujiwara N, Friedman SL, Goossens N, Hoshida Y. Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine. J Hepatol. 2018;68:526\u201349. https:\/\/doi.org\/10.1016\/j.jhep.2017.09.016.","journal-title":"J Hepatol"},{"key":"15839_CR6","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1634\/theoncologist.2011-0447","volume":"17","author":"L Jun","year":"2012","unstructured":"Jun L, Zhenlin Y, Renyan G, Yizhou W, Xuying W, Feng X, et al. Independent factors and predictive score for extrahepatic metastasis of hepatocellular carcinoma following curative hepatectomy. Oncologist. 2012;17:963\u20139. https:\/\/doi.org\/10.1634\/theoncologist.2011-0447.","journal-title":"Oncologist"},{"key":"15839_CR7","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1097\/MEG.0000000000002535","volume":"35","author":"F Xia","year":"2023","unstructured":"Xia F, Zhang Q, Ndhlovu E, Zheng J, Gao H, Xia G. A nomogram for preoperative prediction of microvascular invasion in ruptured hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2023;35:591\u20139. https:\/\/doi.org\/10.1097\/MEG.0000000000002535.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"15839_CR8","doi-asserted-by":"publisher","first-page":"100875","DOI":"10.1016\/j.tranon.2020.100875","volume":"14","author":"C Zhang","year":"2021","unstructured":"Zhang C, Zhao R, Chen F, Zhu Y, Chen L. Preoperative prediction of microvascular invasion in non-metastatic hepatocellular carcinoma based on nomogram analysis. Transl Oncol. 2021;14:100875. https:\/\/doi.org\/10.1016\/j.tranon.2020.100875.","journal-title":"Transl Oncol"},{"key":"15839_CR9","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1097\/SLA.0000000000003268","volume":"273","author":"S Lee","year":"2021","unstructured":"Lee S, Kang TW, Song KD, Lee MW, Rhim H, Lim HK, et al. Effect of microvascular invasion risk on early recurrence of hepatocellular carcinoma after surgery and radiofrequency ablation. Ann Surg. 2021;273:564\u201371. https:\/\/doi.org\/10.1097\/SLA.0000000000003268.","journal-title":"Ann Surg"},{"key":"15839_CR10","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1001\/jamasurg.2015.4257","volume":"151","author":"Z Lei","year":"2016","unstructured":"Lei Z, Li J, Wu D, Xia Y, Wang Q, Si A, et al. Nomogram for preoperative estimation of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma within the Milan criteria. JAMA Surg. 2016;151:356\u201363. https:\/\/doi.org\/10.1001\/jamasurg.2015.4257.","journal-title":"JAMA Surg"},{"key":"15839_CR11","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1148\/radiol.2018181494","volume":"289","author":"V Chernyak","year":"2018","unstructured":"Chernyak V, Fowler KJ, Kamaya A, Kielar AZ, Elsayes KM, Bashir MR, et al. Liver imaging reporting and data system (LI-RADS) version 2018: imaging of hepatocellular carcinoma in at-risk patients. Radiology. 2018;289:816\u201330. https:\/\/doi.org\/10.1148\/radiol.2018181494.","journal-title":"Radiology"},{"key":"15839_CR12","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/hep.27877","volume":"62","author":"S Banerjee","year":"2015","unstructured":"Banerjee S, Wang DS, Kim HJ, Sirlin CB, Chan MG, Korn RL, et al. A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma. Hepatology. 2015;62:792\u2013800. https:\/\/doi.org\/10.1002\/hep.27877.","journal-title":"Hepatology"},{"key":"15839_CR13","first-page":"865","volume":"40","author":"WM Cong","year":"2015","unstructured":"Cong WM, Bu H, Chen J, Dong H, Zhu YY, Feng LH, et al. Evidence-based practice guidelines for the standardized pathological diagnosis of primary liver cancer. Med J Chin Peoples Liberat Army. 2015;40:865\u201372 (2015 ed).","journal-title":"Med J Chin Peoples Liberat Army"},{"key":"15839_CR14","first-page":"153","volume":"23","author":"Chinese Association of Liver Cancer of Chinese Medical Doctor Association","year":"2024","unstructured":"Chinese Association of Liver Cancer of Chinese Medical Doctor Association. Chinese expert consensus on the diagnosis and treatment of hepatocellular carcinoma with microvascular invasion. Chin J Dig Surg. 2024;23:153\u201364 (2024 ed).","journal-title":"Chin J Dig Surg."},{"key":"15839_CR15","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/jmri.27043","volume":"52","author":"SW Sun","year":"2020","unstructured":"Sun SW, Liu QP, Xu X, Zhu FP, Zhang YD, Liu XS. Direct comparison of four presurgical stratifying schemes for prediction of microvascular invasion in hepatocellular carcinoma by gadoxetic acid-enhanced MRI. J Magn Reson Imaging. 2020;52:433\u201347. https:\/\/doi.org\/10.1002\/jmri.27043.","journal-title":"J Magn Reson Imaging"},{"key":"15839_CR16","doi-asserted-by":"publisher","first-page":"102913","DOI":"10.1016\/j.eclinm.2024.102913","volume":"77","author":"F Hou","year":"2024","unstructured":"Hou F, Zhu Y, Zhao H, Cai H, Wang Y, Peng X, et al. Development and validation of an interpretable machine learning model for predicting the risk of distant metastasis in papillary thyroid cancer: A multicenter study. EClinicalmedicine. 2024;77:102913. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102913.","journal-title":"EClinicalmedicine"},{"key":"15839_CR17","doi-asserted-by":"publisher","first-page":"671","DOI":"10.2147\/JHC.S358197","volume":"9","author":"C An","year":"2022","unstructured":"An C, Yang H, Yu X, Han ZY, Cheng Z, Liu F, et al. A machine learning model based on health records for predicting recurrence after microwave ablation of hepatocellular carcinoma. J Hepatocell Carcinoma. 2022;9:671\u201384. https:\/\/doi.org\/10.2147\/JHC.S358197.","journal-title":"J Hepatocell Carcinoma"},{"key":"15839_CR18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/10408363.2020.1828811","volume":"58","author":"S De Bruyne","year":"2021","unstructured":"De Bruyne S, Speeckaert MM, Van Biesen W, Delanghe JR. Recent evolutions of machine learning applications in clinical laboratory medicine. Crit Rev Clin Lab Sci. 2021;58:131\u201352. https:\/\/doi.org\/10.1080\/10408363.2020.1828811.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"15839_CR19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41580-021-00407-0","volume":"23","author":"JG Greener","year":"2022","unstructured":"Greener JG, Kandathil SM, Moffat L, Jones DT. A guide to machine learning for biologists. Nat Rev Mol Cell Biol. 2022;23:40\u201355. https:\/\/doi.org\/10.1038\/s41580-021-00407-0.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"15839_CR20","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.acra.2022.12.018","volume":"30","author":"M Lu","year":"2023","unstructured":"Lu M, Qu Q, Xu L, Zhang J, Liu M, Jiang J, et al. Prediction for aggressiveness and postoperative recurrence of hepatocellular carcinoma using gadoxetic acid-enhanced magnetic resonance imaging. Acad Radiol. 2023;30:841\u201352. https:\/\/doi.org\/10.1016\/j.acra.2022.12.018.","journal-title":"Acad Radiol"},{"key":"15839_CR21","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.jhep.2019.02.023","volume":"70","author":"X Xu","year":"2019","unstructured":"Xu X, Zhang HL, Liu QP, Sun SW, Zhang J, Zhu FP, et al. Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma. J Hepatol. 2019;70:1133\u201344. https:\/\/doi.org\/10.1016\/j.jhep.2019.02.023.","journal-title":"J Hepatol"},{"key":"15839_CR22","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1148\/radiol.2015151169","volume":"278","author":"RJ Gillies","year":"2016","unstructured":"Gillies RJ, Kinahan PE, Hricak HH. Radiomics: Images are more than pictures, they are data. Radiology. 2016;278:563\u201377. https:\/\/doi.org\/10.1148\/radiol.2015151169.","journal-title":"Radiology"},{"key":"15839_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13027-019-0219-8","volume":"14","author":"C Qu","year":"2019","unstructured":"Qu C, Huang X, Liu K, Li K, Tan B, Qu L, et al. Effect of hepatitis B virus DNA replication level and anti-HBV therapy on microvascular invasion of hepatocellular carcinoma. Infect Agent Cancer. 2019;14:2. https:\/\/doi.org\/10.1186\/s13027-019-0219-8.","journal-title":"Infect Agent Cancer"},{"key":"15839_CR24","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1038\/s41598-019-39440-7","volume":"9","author":"K Liu","year":"2019","unstructured":"Liu K, Duan J, Liu H, Yang X, Yang J, Wu M, et al. Precancer antiviral treatment reduces microvascular invasion of early-stage hepatitis B-related hepatocellular carcinoma. Sci Rep. 2019;9:2220. https:\/\/doi.org\/10.1038\/s41598-019-39440-7.","journal-title":"Sci Rep"},{"key":"15839_CR25","doi-asserted-by":"publisher","first-page":"173382","DOI":"10.1016\/j.ejphar.2020.173382","volume":"883","author":"Z Wang","year":"2020","unstructured":"Wang Z, Duan Y, Zhang J, Lv Y, Wu S, Cheng M, et al. Preoperative antiviral therapy and microvascular invasion in hepatitis B virus-related hepatocellular carcinoma: a meta-analysis. Eur J Pharmacol. 2020;883:173382. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173382.","journal-title":"Eur J Pharmacol"},{"key":"15839_CR26","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3389\/fonc.2019.00370","volume":"9","author":"F Yang","year":"2019","unstructured":"Yang F, Ma L, Yang Y, Liu W, Zhao J, Chen X, et al. Contribution of hepatitis B virus infection to the aggressiveness of primary liver cancer: a clinical epidemiological study in Eastern China. Front Oncol. 2019;9:370. https:\/\/doi.org\/10.3389\/fonc.2019.00370.","journal-title":"Front Oncol"},{"key":"15839_CR27","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1053\/j.gastro.2012.03.053","volume":"143","author":"J Xu","year":"2012","unstructured":"Xu J, Liu H, Chen L, Wang S, Zhou L, Yun X, et al. Hepatitis B virus X protein confers resistance of hepatoma cells to anoikis by up-regulating and activating p21-activated kinase 1. Gastroenterology. 2012;143:199-212.e4. https:\/\/doi.org\/10.1053\/j.gastro.2012.03.053.","journal-title":"Gastroenterology"},{"key":"15839_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M, et al. NF-\u03baB in biology and targeted therapy: new insights and translational implications. Signal Transduct Target Ther. 2024;9:53. https:\/\/doi.org\/10.1038\/s41392-024-01757-9.","journal-title":"Signal Transduct Target Ther"},{"key":"15839_CR29","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","volume":"8","author":"ZL Liu","year":"2023","unstructured":"Liu ZL, Chen HH, Zheng LL, Sun LP, Shi L. Angiogenic signaling pathways and anti-angiogenic therapy for cancer. Signal Transduct Target Ther. 2023;8:198. https:\/\/doi.org\/10.1038\/s41392-023-01460-1.","journal-title":"Signal Transduct Target Ther"},{"key":"15839_CR30","doi-asserted-by":"publisher","first-page":"652","DOI":"10.4103\/jcrt.JCRT_1714_20","volume":"17","author":"H Li","year":"2021","unstructured":"Li H, Li T, Hu J, Liu J. A nomogram to predict microvascular invasion in early hepatocellular carcinoma. J Cancer Res Ther. 2021;17:652\u20137. https:\/\/doi.org\/10.4103\/jcrt.JCRT_1714_20.","journal-title":"J Cancer Res Ther"},{"key":"15839_CR31","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12893-023-02139-8","volume":"23","author":"L Yu","year":"2023","unstructured":"Yu L, Dai MG, Lu WF, Wang DD, Ye TW, Xu FQ, et al. Preoperative prediction model for microvascular invasion in HBV-related intrahepatic cholangiocarcinoma. BMC Surg. 2023;23:239. https:\/\/doi.org\/10.1186\/s12893-023-02139-8.","journal-title":"BMC Surg"},{"key":"15839_CR32","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1097\/SLA.0000000000002552","volume":"267","author":"GA Margonis","year":"2018","unstructured":"Margonis GA, Sergentanis TN, Ntanasis-Stathopoulos I, Andreatos N, Tzanninis IG, Sasaki K, et al. Impact of surgical margin width on recurrence and overall survival following R0 hepatic resection of colorectal metastases: a systematic review and meta-analysis. Ann Surg. 2018;267:1047\u201355. https:\/\/doi.org\/10.1097\/SLA.0000000000002552.","journal-title":"Ann Surg"},{"key":"15839_CR33","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1148\/radiol.2501071702","volume":"250","author":"K Ishigami","year":"2009","unstructured":"Ishigami K, Yoshimitsu K, Nishihara Y, Irie H, Asayama Y, Tajima T, et al. Hepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images: correlation with histopathologic findings. Radiology. 2009;250:435\u201343. https:\/\/doi.org\/10.1148\/radiol.2501071702.","journal-title":"Radiology"},{"key":"15839_CR34","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1007\/s00330-006-0203-8","volume":"16","author":"JH Lim","year":"2006","unstructured":"Lim JH, Choi D, Park CK, Lee WJ, Lim HK. Encapsulated hepatocellular carcinoma: CT-pathologic correlations. Eur Radiol. 2006;16:2326\u201333. https:\/\/doi.org\/10.1007\/s00330-006-0203-8.","journal-title":"Eur Radiol"},{"issue":"11","key":"15839_CR35","first-page":"50","volume":"13","author":"YF Xiong","year":"2015","unstructured":"Xiong YF, Zhang XM, Yang L, Min XL, Peng J, Yang KA. Study of the correlation between the features of multislice computed tomography and angiogenesis in hepatocellular carcinomas. Chin J CT MRI. 2015;13(11):50\u20133.","journal-title":"Chin J CT MRI"},{"key":"15839_CR36","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1186\/1471-2407-11-486","volume":"11","author":"PA Fasching","year":"2011","unstructured":"Fasching PA, Heusinger K, Haeberle L, Niklos M, Hein A, Bayer CM, et al. Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment. BMC Cancer. 2011;11:486. https:\/\/doi.org\/10.1186\/1471-2407-11-486.","journal-title":"BMC Cancer"},{"key":"15839_CR37","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/labinvest.2013.128","volume":"94","author":"JR Brown","year":"2014","unstructured":"Brown JR, DiGiovanna MP, Killelea B, Lannin DR, Rimm DL. Quantitative assessment Ki-67 score for prediction of response to neoadjuvant chemotherapy in breast cancer. Lab Invest. 2014;94:98\u2013106. https:\/\/doi.org\/10.1038\/labinvest.2013.128.","journal-title":"Lab Invest"},{"key":"15839_CR38","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","volume":"19","author":"C Saut\u00e8s-Fridman","year":"2019","unstructured":"Saut\u00e8s-Fridman C, Petitprez F, Calderaro J, Fridman WH. Tertiary lymphoid structures in the era of cancer immunotherapy. Nat Rev Cancer. 2019;19:307\u201325. https:\/\/doi.org\/10.1038\/s41568-019-0144-6.","journal-title":"Nat Rev Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15839-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15839-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15839-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:23:58Z","timestamp":1776669838000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15839-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15839"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15839-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"assertion":[{"value":"23 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Clinical Research Ethics Committee of Shenzhen People's Hospital (approval number: LL-KY-2025126\u201301).The Clinical Research Ethics Committee of Shenzhen People's Hospital waived the requirement for obtaining written informed consent for this retrospective analysis. All procedures involving human participants were performed in accordance with the 1975 Helsinki declaration and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"499"}}